Bulletin
Investor Alert

Roche Holding AG Part. Cert.

OTC: RHHVF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Nov 26, 2021, 12:54 p.m.

/zigman2/quotes/206948568/composite

$

383.50

Change

-5.00 -1.29%

Volume

Volume 103

Quotes are delayed by 20 min

/zigman2/quotes/206948568/composite

Previous close

$ 388.50

$ 383.50

Change

-5.00 -1.29%

Day low

Day high

$383.50

$394.00

Open

52 week low

52 week high

$308.57

$411.44

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Dr. Severin Schwan
Chief Executive Officer & Executive Director
Dr. Alan Hippe
Chief Financial & Information Officer
Ms. Pascale Schmidt
Chief Compliance Officer
Dr. Gallia G. Levy
Associate Group Medical Director-Hematology
Dr. William Pao
Head-Pharma Research & Early Development
Mr. Per-Olof Attinger
Secretary-Executive Committee & Head-CEO Office
Dr. Karsten Jung
Global Product Strategy Head
Dr. Pablo Umaña
Head-Cancer Immunotherapy Discovery
Mr. Jason S. Ehrlich
Senior Group Medical Director
Mr. Paul Bulcke
Independent Non-Executive Director
Dr. Karl Mahler
Head-Investor Relations
Ms. Cristina A. Wilbur
Chief People Officer
Dr. Annette Luther
Secretary
Ms. Claudia Boeckstiegel
General Counsel
Dr. Christoph Franz
Chairman
Dr. Joerg Duschmale
Independent Non-Executive Director
Dr. Patrick Frost
Independent Non-Executive Director
Mr. Bernard J. Poussot
Independent Non-Executive Director
Dr. Richard P. Lifton
Independent Non-Executive Director
Dr. Claudia Süssmuth Dyckerhoff
Independent Non-Executive Director
Ms. Julie Brown
Independent Non-Executive Director
Ms. Anita Hauser
Independent Non-Executive Director
Dr. Hans Clevers
Independent Non-Executive Director
Mr. André S. Hoffmann
Vice Chairman
Link to MarketWatch's Slice.